MELANOMA OF UNKNOWN PRIMARY
Clinical trials for MELANOMA OF UNKNOWN PRIMARY explained in plain language.
Never miss a new study
Get alerted when new MELANOMA OF UNKNOWN PRIMARY trials appear
Sign up with your email to follow new studies for MELANOMA OF UNKNOWN PRIMARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Melanoma drug combo trial halted after just 3 patients
Disease control TerminatedThis study tested two drugs, encorafenib and binimetinib, given before surgery to people with a certain type of advanced melanoma (stage IIIB-D) that had spread to lymph nodes. The goal was to see if the drugs could shrink or eliminate the cancer before removal. The trial was sto…
Matched conditions: MELANOMA OF UNKNOWN PRIMARY
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 20, 2026 11:53 UTC
-
Promising combo for brain metastases trial halted after just one patient
Symptom relief TerminatedThis early-stage trial aimed to see if adding a device that sends gentle electric fields (tumor treating fields) to standard radiation and immunotherapy could help people with melanoma that spread to the brain. Only one person took part before the study was stopped early. The mai…
Matched conditions: MELANOMA OF UNKNOWN PRIMARY
Phase: PHASE1 • Sponsor: Emory University • Aim: Symptom relief
Last updated May 20, 2026 12:08 UTC